Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Acknowledgements to Reviewers:
Volume: 15 Issue: 2
Export Options
About this article
Cite this article as:
Acknowledgements to Reviewers:, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2015; 15 (2) . https://dx.doi.org/10.2174/187152221502151013172046
DOI https://dx.doi.org/10.2174/187152221502151013172046 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
Related Books
20
Related Articles
-
Anti-Arrhythmic Properties of N-3 Poly-Unsaturated Fatty Acids (n-3 PUFA)
Current Medicinal Chemistry [177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma
Current Radiopharmaceuticals Peptide Microarrays: Next Generation Biochips for Detection, Diagnostics and High-Throughput Screening
Current Pharmaceutical Design Preconception Counselling: A Five- Year Experience in a Teratology Information Service
Letters in Drug Design & Discovery Diabetes-induced Alterations in HDL Subfractions Distribution
Current Pharmaceutical Design Pain and Child: A Translational Hypothesis on the Pathophysiology of a Mild Type-2 Diabetes Model
Endocrine, Metabolic & Immune Disorders - Drug Targets Choice of Antihypertensive Treatment in Subjects with Pre-Diabetes. Is There a Dream After the Navigator
Current Vascular Pharmacology Contraindications for Anticoagulation in Older Patients with Atrial Fibrillation: A Narrative Review
Current Drug Safety Capillary Electrophoresis–Mass Spectrometry in Metabolomics: The Potential for Driving Drug Discovery and Development
Current Drug Metabolism Life or Death? A Physiogenomic Approach to Understand Individual Variation in Responses to Hemorrhagic Shock
Current Genomics Diabetic Cardiomyopathy and its Prevention by Metallothionein: Experimental Evidence, Possible Mechanisms and Clinical Implications
Current Medicinal Chemistry Relaxin: New Functions for an Old Peptide
Current Protein & Peptide Science Serum Insulin Degrading Enzyme Level and Other Factors in Type 2 Diabetic Patients with Mild Cognitive Impairment
Current Alzheimer Research Dietary Transition in the South Asian Diaspora: Implications for Diabetes Prevention Strategies
Current Diabetes Reviews Overdoses of Acetaminophen Disrupt the Thyroid-Liver Axis in Neonatal Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Development and Evaluation of Novel Tabletted Microspheres for Controlled Release of Glimepiride
Current Drug Therapy A Two QSAR Way for Antidiabetic Agents Targeting Using α-Amylase and α-Glucosidase Inhibitors: Model Parameters Settings in Artificial Intelligence Techniques
Letters in Drug Design & Discovery Pharmacogenomics
Current Drug Metabolism Development of Heparanase Inhibitors for Anti-Cancer Therapy
Current Medicinal Chemistry Recent U.S. Patents on Protein Drug Formulation: 2000-2007
Recent Patents on Drug Delivery & Formulation